This episode provides timely coverage of the 2025 Meeting of the International Myeloma Society (IMS). Claudio Cerchione highlights the most important developments from the Annual Meeting, offers his reflections on the evolving treatment landscape, and discusses the role of research and collaboration in moving closer to a cure for myeloma.  Timestamps   00:00 – Introduction  02:08 – Reflections on his own career  04:20 – Claudio's initial interest in the field  06:46 – Key takeaways from IMS 2025 Meeting  10:09 – Any potential gaps in coverage?  11:50 – How different patient groups are identified  13:30 – Minimal residual disease  16:15 – Impact of medical societies  20:24 – Translating new findings into clinical practice  23:44 – Improving the accessibility of treatments  26:45 – Claudio's key takeaways from IMS 2025 Meeting  Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ. 

Ver todos los episodios